Cargando…
Pregnancy-specific beta 1-glycoprotein (SP1) in serum and tissue from patients with benign and malignant breast tumours.
Autores principales: | Sørensen, S., Andersen, J., Nørgaard, T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1984
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976724/ https://www.ncbi.nlm.nih.gov/pubmed/6609709 |
Ejemplares similares
-
Pregnancy-specific beta glycoprotein (SP1) in tumours of the human gastrointestinal tract.
por: Skinner, J. M., et al.
Publicado: (1981) -
Investigation of Serum Pregnancy-Specific Beta-1-Glycoprotein and Relationship with Fetal Growth Restriction
por: Tuzluoğlu, Sabiha, et al.
Publicado: (2022) -
Serum levels of human placental lactogen and pregnancy-specific beta 1-glycoprotein in breast cancer.
por: Monteiro, J. C., et al.
Publicado: (1982) -
Pregnancy-Specific Beta-1-Glycoprotein: The Player of the Game in
predicting adverse outcomes in pregnancy
por: Toprak, Kenan, et al.
Publicado: (2023) -
Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignancies.
por: Scambia, G., et al.
Publicado: (1990)